WallStSmart

Airsculpt Technologies Inc (AIRS)vsThe Ensign Group Inc (ENSG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Ensign Group Inc generates 3110% more annual revenue ($5.06B vs $157.55M). ENSG leads profitability with a 6.8% profit margin vs -11.4%. ENSG earns a higher WallStSmart Score of 57/100 (C).

AIRS

Hold

40

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 5.0Quality: 4.0
Piotroski: 1/9Altman Z: 0.94

ENSG

Buy

57

out of 100

Grade: C

Growth: 8.0Profit: 6.0Value: 8.0Quality: 5.8
Piotroski: 5/9Altman Z: 2.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AIRS.

ENSGFair Value (-0.3%)

Margin of Safety

-0.3%

Fair Value

$211.28

Current Price

$203.89

$7.39 premium

UndervaluedFair: $211.28Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AIRS1 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

ENSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
20.2%8/10

Revenue surging 20.2% year-over-year

Areas to Watch

AIRS4 concerns · Avg: 3.3/10
EPS GrowthGrowth
2.0%4/10

2.0% earnings growth

Market CapQuality
$165.46M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.033/10

Elevated debt levels

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

ENSG3 concerns · Avg: 3.7/10
PEG RatioValuation
1.784/10

Expensive relative to growth rate

P/E RatioValuation
35.0x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
6.8%3/10

6.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : AIRS

The strongest argument for AIRS centers on Price/Book.

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 20.2% demonstrates continued momentum.

Bear Case : AIRS

The primary concerns for AIRS are EPS Growth, Market Cap, Debt/Equity.

Bear Case : ENSG

The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.

Key Dynamics to Monitor

AIRS profiles as a turnaround stock while ENSG is a growth play — different risk/reward profiles.

AIRS carries more volatility with a beta of 2.80 — expect wider price swings.

ENSG is growing revenue faster at 20.2% — sustainability is the question.

ENSG generates stronger free cash flow (133M), providing more financial flexibility.

Bottom Line

ENSG scores higher overall (57/100 vs 40/100) and 20.2% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Airsculpt Technologies Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Airsculpt Technologies Inc (AIRS) is at the forefront of the aesthetic medical technology sector, renowned for its innovative AirSculpt® procedure, which provides minimally invasive body contouring solutions. The company prioritizes patient safety and comfort while delivering remarkable aesthetic outcomes, thereby transforming the cosmetic surgery experience. With a robust network of licensed practitioners and a strong commitment to technological advancement, Airsculpt is strategically positioned to capitalize on the increasing global demand for non-invasive cosmetic procedures, aiming to enhance its market presence and diversify its offerings. This proactive approach not only drives immediate growth but also sets the foundation for sustainable long-term value creation for its investors.

Visit Website →

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Want to dig deeper into these stocks?